Click here to get full coverage on Pliant Therapeutics (Nasdaq: PLRX) reports interim PLN-101095 data with 1 CR, 3 PRs - Stock Titan

Pliant Therapeutics (Nasdaq: PLRX) reports interim PLN-101095 data with 1 CR, 3 PRs  Stock Titan

Pliant Therapeutics (Nasdaq: PLRX) reports interim PLN-101095 data with 1 CR, 3 PRs - Stock Titan

Click here to get full coverage on New Analyst Forecast: $PLRX Given 'Underweight' Rating | PLRX Stock News - Quiver Quantitative

New Analyst Forecast: $PLRX Given 'Underweight' Rating | PLRX Stock News  Quiver Quantitative

New Analyst Forecast: $PLRX Given 'Underweight' Rating | PLRX Stock News - Quiver Quantitative

Click here to get full coverage on Pliant Therapeutics Announces Departure of Chief Medical Officer - TipRanks

Pliant Therapeutics Announces Departure of Chief Medical Officer  TipRanks

Pliant Therapeutics Announces Departure of Chief Medical Officer - TipRanks

Click here to get full coverage on Why Is Pliant Therapeutics Stock Trading Lower Today - Pliant Therapeutics (NASDAQ:PLRX) - Benzinga

Why Is Pliant Therapeutics Stock Trading Lower Today - Pliant Therapeutics (NASDAQ:PLRX)  Benzinga

Why Is Pliant Therapeutics Stock Trading Lower Today - Pliant Therapeutics (NASDAQ:PLRX) - Benzinga

Click here to get full coverage on PLRX Stock Plunges 89% in 3 Months: Here's What Investors Should Know - Nasdaq

PLRX Stock Plunges 89% in 3 Months: Here's What Investors Should Know  Nasdaq

PLRX Stock Plunges 89% in 3 Months: Here's What Investors Should Know - Nasdaq

Click here to get full coverage on Pliant Therapeutics Stock: An Activist On Deck (NASDAQ:PLRX) - Seeking Alpha

Pliant Therapeutics Stock: An Activist On Deck (NASDAQ:PLRX)  Seeking Alpha

Pliant Therapeutics Stock: An Activist On Deck (NASDAQ:PLRX) - Seeking Alpha

Click here to get full coverage on Pliant Therapeutics Provides Corporate Update and Reports Second Quarter 2025 Financial Results - GlobeNewswire

Pliant Therapeutics Provides Corporate Update and Reports Second Quarter 2025 Financial Results  GlobeNewswire

Pliant Therapeutics Provides Corporate Update and Reports Second Quarter 2025 Financial Results - GlobeNewswire

Click here to get full coverage on J.P. Morgan Maintains Pliant Therapeutics(PLRX.US) With Sell Rating - 富途牛牛

J.P. Morgan Maintains Pliant Therapeutics(PLRX.US) With Sell Rating  富途牛牛

J.P. Morgan Maintains Pliant Therapeutics(PLRX.US) With Sell Rating - 富途牛牛

Click here to get full coverage on Pliant Therapeutics to Participate in the Piper Sandler Healthcare Conference - Investing News Network

Pliant Therapeutics to Participate in the Piper Sandler Healthcare Conference  Investing News Network

Pliant Therapeutics to Participate in the Piper Sandler Healthcare Conference - Investing News Network

Click here to get full coverage on 3 Promising Penny Stocks With Market Caps Under $200M - simplywall.st

3 Promising Penny Stocks With Market Caps Under $200M  simplywall.st

3 Promising Penny Stocks With Market Caps Under $200M - simplywall.st

Click here to get full coverage on Will PLRX stock maintain momentum in 2025 - July 2025 Setups & Reliable Intraday Trade Alerts - moha.gov.vn

Will PLRX stock maintain momentum in 2025 - July 2025 Setups & Reliable Intraday Trade Alerts  moha.gov.vn

Will PLRX stock maintain momentum in 2025 - July 2025 Setups & Reliable Intraday Trade Alerts - moha.gov.vn

Click here to get full coverage on PLRX - Pliant Therapeutics, Inc. Latest Stock News & Market Updates - Stock Titan

PLRX - Pliant Therapeutics, Inc. Latest Stock News & Market Updates  Stock Titan

PLRX - Pliant Therapeutics, Inc. Latest Stock News & Market Updates - Stock Titan

Click here to get full coverage on Pliant Therapeutics to Participate in the Piper Sandler Healthcare Conference - GlobeNewswire

Pliant Therapeutics to Participate in the Piper Sandler Healthcare Conference  GlobeNewswire

Pliant Therapeutics to Participate in the Piper Sandler Healthcare Conference - GlobeNewswire

Click here to get full coverage on Pliant Therapeutics: Strange Volatility (NASDAQ:PLRX) - Seeking Alpha

Pliant Therapeutics: Strange Volatility (NASDAQ:PLRX)  Seeking Alpha

Pliant Therapeutics: Strange Volatility (NASDAQ:PLRX) - Seeking Alpha

Click here to get full coverage on $PLRX stock is up 22% today. Here's what we see in our data. - Quiver Quantitative

$PLRX stock is up 22% today. Here's what we see in our data.  Quiver Quantitative

$PLRX stock is up 22% today. Here's what we see in our data. - Quiver Quantitative

Click here to get full coverage on Pliant Therapeutics Provides Corporate Update and Reports First Quarter 2025 Financial Results - GlobeNewswire

Pliant Therapeutics Provides Corporate Update and Reports First Quarter 2025 Financial Results  GlobeNewswire

Pliant Therapeutics Provides Corporate Update and Reports First Quarter 2025 Financial Results - GlobeNewswire

Click here to get full coverage on Allogene, Pliant down as J.P. Morgan cuts to Underweight on uncertain outlook - Seeking Alpha

Allogene, Pliant down as J.P. Morgan cuts to Underweight on uncertain outlook  Seeking Alpha

Allogene, Pliant down as J.P. Morgan cuts to Underweight on uncertain outlook - Seeking Alpha

Click here to get full coverage on Pliant Therapeutics Provides Corporate Update and Reports Third Quarter 2025 Financial Results - GlobeNewswire

Pliant Therapeutics Provides Corporate Update and Reports Third Quarter 2025 Financial Results  GlobeNewswire

Pliant Therapeutics Provides Corporate Update and Reports Third Quarter 2025 Financial Results - GlobeNewswire

Click here to get full coverage on Pliant Therapeutics Provides Update on BEACON-IPF - GlobeNewswire

Pliant Therapeutics Provides Update on BEACON-IPF  GlobeNewswire

Pliant Therapeutics Provides Update on BEACON-IPF - GlobeNewswire

Click here to get full coverage on Pliant Therapeutics Inc reports results for the quarter ended September 30 - Earnings Summary - TradingView — Track All Markets

Pliant Therapeutics Inc reports results for the quarter ended September 30 - Earnings Summary  TradingView — Track All Markets

Pliant Therapeutics Inc reports results for the quarter ended September 30 - Earnings Summary - TradingView — Track All Markets

Click here to get full coverage on Pliant Therapeutics Announces CBO Hans Hull’s Resignation - TipRanks

Pliant Therapeutics Announces CBO Hans Hull’s Resignation  TipRanks

Pliant Therapeutics Announces CBO Hans Hull’s Resignation - TipRanks

Click here to get full coverage on Penny Stocks To Watch With Market Caps Under $700M - simplywall.st

Penny Stocks To Watch With Market Caps Under $700M  simplywall.st

Penny Stocks To Watch With Market Caps Under $700M - simplywall.st

Click here to get full coverage on Pliant Therapeutics Announces Strategic Realignment of Workforce and Operations - GlobeNewswire

Pliant Therapeutics Announces Strategic Realignment of Workforce and Operations  GlobeNewswire

Pliant Therapeutics Announces Strategic Realignment of Workforce and Operations - GlobeNewswire

Click here to get full coverage on symbol__ Stock Quote Price and Forecast - CNN

symbol__ Stock Quote Price and Forecast  CNN

symbol__ Stock Quote Price and Forecast - CNN

Click here to get full coverage on Pliant touches record low after scrapping trial of lung-disease drug - TradingView — Track All Markets

Pliant touches record low after scrapping trial of lung-disease drug  TradingView — Track All Markets

Pliant touches record low after scrapping trial of lung-disease drug - TradingView — Track All Markets

Click here to get full coverage on TANG CAPITAL MANAGEMENT LLC Acquires Significant Stake in Pliant Therapeutics Inc - GuruFocus

TANG CAPITAL MANAGEMENT LLC Acquires Significant Stake in Pliant Therapeutics Inc  GuruFocus

TANG CAPITAL MANAGEMENT LLC Acquires Significant Stake in Pliant Therapeutics Inc - GuruFocus

Click here to get full coverage on PLRX Stock Price and Chart — NASDAQ:PLRX - TradingView — Track All Markets

PLRX Stock Price and Chart — NASDAQ:PLRX  TradingView — Track All Markets

PLRX Stock Price and Chart — NASDAQ:PLRX - TradingView — Track All Markets

Click here to get full coverage on Check out Pliant Therapeutics's stock price (PLRX) in real time - CNBC

Check out Pliant Therapeutics's stock price (PLRX) in real time  CNBC

Check out Pliant Therapeutics's stock price (PLRX) in real time - CNBC

Click here to get full coverage on Drug developers Pliant and Acelyrin adopt poison pill provisions to fend off activist investor - The Business Journals

Drug developers Pliant and Acelyrin adopt poison pill provisions to fend off activist investor  The Business Journals

Drug developers Pliant and Acelyrin adopt poison pill provisions to fend off activist investor - The Business Journals

Click here to get full coverage on Paradigm Biocapital Advisors LP Acquires New Stake in Pliant Therapeutics Inc - Yahoo Finance

Paradigm Biocapital Advisors LP Acquires New Stake in Pliant Therapeutics Inc  Yahoo Finance

Paradigm Biocapital Advisors LP Acquires New Stake in Pliant Therapeutics Inc - Yahoo Finance

Click here to get full coverage on Why Is Pliant Therapeutics (PLRX) Stock Up 62% Today? - InvestorPlace

Why Is Pliant Therapeutics (PLRX) Stock Up 62% Today?  InvestorPlace

Why Is Pliant Therapeutics (PLRX) Stock Up 62% Today? - InvestorPlace

Click here to get full coverage on Pliant Therapeutics: Targeting Idiopathic Pulmonary Fibrosis (NASDAQ:PLRX) - Seeking Alpha

Pliant Therapeutics: Targeting Idiopathic Pulmonary Fibrosis (NASDAQ:PLRX)  Seeking Alpha

Pliant Therapeutics: Targeting Idiopathic Pulmonary Fibrosis (NASDAQ:PLRX) - Seeking Alpha

Click here to get full coverage on Pliant Therapeutics: Latest Financials Support Stable Investment In Future Growth (PLRX) - Seeking Alpha

Pliant Therapeutics: Latest Financials Support Stable Investment In Future Growth (PLRX)  Seeking Alpha

Pliant Therapeutics: Latest Financials Support Stable Investment In Future Growth (PLRX) - Seeking Alpha

Click here to get full coverage on Alnylam, Pliant among stocks yet to face Q2 catalysts: Wells Fargo - Seeking Alpha

Alnylam, Pliant among stocks yet to face Q2 catalysts: Wells Fargo  Seeking Alpha

Alnylam, Pliant among stocks yet to face Q2 catalysts: Wells Fargo - Seeking Alpha

Click here to get full coverage on 7 Biotech Stocks to Buy on the Dip: June 2024 - Yahoo Finance

7 Biotech Stocks to Buy on the Dip: June 2024  Yahoo Finance

PLRX

Price Chart

Key Statistics

Technicals

About PLRX

Latest News

Pliant Therapeutics (Nasdaq: PLRX) reports interim PLN-101095 data with 1 CR, 3 PRs - Stock Titan

New Analyst Forecast: $PLRX Given 'Underweight' Rating | PLRX Stock News - Quiver Quantitative

Pliant Therapeutics Announces Departure of Chief Medical Officer - TipRanks

Advanced Charts

Top Gainers

Top Losers